Presbyterian Kaseman Hospital - New Mexico Cancer Research Alliance (NMCRA)
Albuquerque, NM
Filters
Save & Share
Clear Filters
Diagnosis
Treatment History
Not yet accepting
OPTIMMAL
An Open-Label, Non-Randomized, Multicenter, Phase II Study to Study the Efficacy of Talquetamab (JNJ-64407564) and Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma (OPTIMMAL)
Learn more- Bispecific Antibody
- GPRC5D
- Maintenance
- Phase 2
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials